Cipremi

Cipla launches remdesivir under brand name CIPREMI

HTP Desk - 0
hydroxychloroquine

DGFT lifts ban on export of hydroxychloroquine, API and formulation

HTP Desk - 0
hydroxychloroquine

NIH halts clinical trial of hydroxychloroquine

HTP Desk - 0
hydrochloroquine

Novartis discontinues hydroxychloroquine clinical trial

HTP Desk - 0
Glenmark

Glenmark gets nod from DCGI for Favipiravir launch

HTP Desk - 0
diagnostic kits

IIT Guwahati develops affordable diagnostic kits for coronavirus

HTP Desk - 0
Asend

Ascend launches Acteev Protect antimicrobial technology

HTP Desk - 0
Sabic Purecare

Sabic Purecares offers solutions for medical disposables

HTP Desk - 0
knee replacements

Reimagining knee replacements with additive technology and AI

HTP Desk - 0
Umifenovir

Umifenovir gets DCGI approval for Phase III clinical trial

HTP Desk - 0
Load more